University of Minho   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Braga Portugal (1973)

Organization Overview

First Clinical Trial
2017
NCT03585218
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Psychological Neuroscience Laboratory, Psychology Research Center, University of Minho, Portugal. | University of Minho | University of Minho, School of Psychology

Active Ingredients

Drugs in Phase 4 Trials (2)

levobupivacaine (chirocaine) (1 trial)

triamcinolone (kenalog) (1 trial)

Drugs in Phase 3 Trials (1)

essential oils (1 trial)

Drugs in Phase 2 Trials (4)

inulin (1 trial)

maltodextrin (1 trial)

pramipexole (mirapex) (1 trial)

risperidone (risperdal) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Back Pain (Phase 4)

Breast Neoplasms (Phase 3)

Low Back Pain (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 7